MYX 2.39% $4.50 mayne pharma group limited

Do you even read and test what you post? So again, Nextstellis...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 167 Posts.
    lightbulb Created with Sketch. 95
    Do you even read and test what you post? So again, Nextstellis have been a continued disappointment to MYX because the company *continues* to miss any target or forecast set.

    Your post quotes the company:
    https://hotcopper.com.au/data/attachments/5634/5634954-94add7028a2cd06e67e251a5579e0d68.jpg

    The actuals from the Annual Report (period ending June 2023:

    https://hotcopper.com.au/data/attachments/5634/5634957-dbdf90586ae84b8808882dc81088b5c3.jpg

    But investors are wrong, even when they are reacting to the actuals that the company is posting.

    I'm an investor - so I really hope they sort this shit out - but they need to get real first... They need to clean up the S+M budget, which they started with the addition of more products... But it isn't just good buying product to better utilise an S+M department, they are paying good $ for these products and therefore they need to retain market share too (the initial concern with TxMD and derm).



 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.